Jane Street’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.69M | Sell |
9,442
-66,511
| -88% | -$19.6M | ﹤0.01% | 4665 |
|
|
2026
Q1 | $22.6M | Buy |
+75,953
| New | +$24.6M | ﹤0.01% | 1679 |
|
|
2025
Q4 | – | Sell |
-13,078
| Closed | -$4.28M | – | 12778 |
|
|
2025
Q3 | $4.46M | Sell |
13,078
-12,092
| -48% | -$3.67M | ﹤0.01% | 3597 |
|
|
2025
Q2 | $6.09M | Sell |
25,170
-64,557
| -72% | -$15.8M | ﹤0.01% | 2739 |
|
|
2025
Q1 | $24.4M | Buy |
89,727
+66,853
| +292% | +$15.6M | 0.01% | 1149 |
|
|
2024
Q4 | $4.23M | Sell |
22,874
-5,075
| -18% | -$1.04M | ﹤0.01% | 2904 |
|
|
2024
Q3 | $6.27M | Buy |
27,949
+11,916
| +74% | +$2.14M | ﹤0.01% | 2499 |
|
|
2024
Q2 | $2.29M | Buy |
+16,033
| New | +$2.47M | ﹤0.01% | 4253 |
|
|
2024
Q1 | – | Sell |
-13,580
| Closed | -$2.19M | – | 10248 |
|
|
2023
Q4 | $2.45M | Sell |
13,580
-25,632
| -65% | -$4.64M | ﹤0.01% | 3974 |
|
|
2023
Q3 | $7.05M | Buy |
39,212
+34,143
| +674% | +$6.76M | ﹤0.01% | 2178 |
|
|
2023
Q2 | $904K | Buy |
5,069
+29
| +0.6% | +$6.68K | ﹤0.01% | 5359 |
|
|
2023
Q1 | $1.09M | Sell |
5,040
-51,201
| -91% | -$12.3M | ﹤0.01% | 4843 |
|
|
2022
Q4 | $12.4M | Buy |
+56,241
| New | +$10.3M | 0.01% | 1412 |
|
|
2022
Q3 | – | Sell |
-13,802
| Closed | -$2.37M | – | 10638 |
|
|
2022
Q2 | $2.23M | Sell |
13,802
-44,238
| -76% | -$6.91M | ﹤0.01% | 3958 |
|
|
2022
Q1 | $10.9M | Buy |
58,040
+32,425
| +127% | +$6.89M | ﹤0.01% | 1884 |
|
|
2021
Q4 | $6.94M | Buy |
25,615
+23,746
| +1,271% | +$8.02M | ﹤0.01% | 2367 |
|
|
2021
Q3 | $678K | Sell |
1,869
-9,421
| -83% | -$3.08M | ﹤0.01% | 6706 |
|
|
2021
Q2 | $3.88M | Sell |
11,290
-17,186
| -60% | -$5.69M | ﹤0.01% | 3089 |
|
|
2021
Q1 | $9.91M | Buy |
28,476
+10,104
| +55% | +$3.35M | ﹤0.01% | 1554 |
|
|
2020
Q4 | $4.75M | Sell |
18,372
-2,669
| -13% | -$735K | ﹤0.01% | 2198 |
|
|
2020
Q3 | $6.03M | Buy |
+21,041
| New | +$4.95M | ﹤0.01% | 1660 |
|
|
2019
Q3 | – | Sell |
-6,838
| Closed | -$847K | – | 5885 |
|
|
2019
Q2 | $847K | Buy |
+6,838
| New | +$868K | ﹤0.01% | 2914 |
|
|
2019
Q1 | – | Sell |
-2,747
| Closed | -$385K | – | 5762 |
|
|
2018
Q4 | $385K | Sell |
2,747
-6,216
| -69% | -$824K | ﹤0.01% | 3774 |
|
|
2018
Q3 | $1.54M | Buy |
8,963
+1,666
| +23% | +$280K | ﹤0.01% | 2194 |
|
|
2018
Q2 | $1.12M | Buy |
+7,297
| New | +$1.3M | ﹤0.01% | 2595 |
|
|
2017
Q4 | – | Sell |
-3,276
| Closed | -$339K | – | 5281 |
|
|
2017
Q3 | $339K | Buy |
+3,276
| New | +$244K | ﹤0.01% | 3543 |
|
Other funds holding ONC
BBA
Jane Street's ONC Position: Q2 2026 in Review
Jane Street reduced its BeOne Medicines Ltd (ONC) stake by 88% in Q2 2026, selling an estimated $19.6M and leaving 9,442 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #4665.
Jane Street first reported a position in ONC in Q3 2017 and has held it in 26 quarters since. The position peaked at $24.4M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Jane Street held 9,442 shares of BeOne Medicines Ltd worth $2.69M as of Q2 2026.
- Jane Street sold 66,511 BeOne Medicines Ltd shares in Q2 2026, an estimated $19.6M.
- BeOne Medicines Ltd made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4665 holding.
- Jane Street first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 26 quarters since.
- Jane Street's BeOne Medicines Ltd position peaked at $24.4M in Q1 2025.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.